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Dual Effect of Glycine on NMDA-Induced Neurotoxicity in Rat Cortical 
Cultures 
Dennis McNamara and Raymond Dingledine 
Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 
To examine the roles of glycine in neurotoxicity caused by 
NMDA, primary rat cortical cultures were exposed to lOO- 
300 PM NMDA plus glycine (o-3000 PM) or other glycine an- 
alogs in a simple saline solution, and toxicity was assessed 
by the amount of lactate dehydrogenase (LDH) released from 
the cultures. NMDA-induced neurotoxicity was abolished by 
100 PM D-2-amino-5-phosphonovaleric acid (D-APV), phen- 
cyclidine (IQ,, 4.1 PM), and Mg (I&,,, 7.5 mu), or by reducing 
[Cal, to 0.1 mu. NMDA-induced neurotoxicity could also be 
abolished by 7-chlorokynurenic acid (I&,, 8.8 PM), suggest- 
ing the presence of residual glycine in the culture medium 
(confirmed by high-performance liquid chromatography 
measurement). Moreover, in the presence of 30 AM 7-chlo- 
rokynurenic acid, glycine, o-serine, o-alanine, B-fluoro-o-al- 
anine, and 1 -aminocyclopropanecarboxylic acid could re- 
store the neurotoxic action of NMDA, and their relative 
potencies and relative efficacies were the same as mea- 
sured in electrophysiological assays in Xenopus oocytes or 
cultured neurons. 
The addition of > 100 PM glycine doubled the excitotoxic 
effect of NMDA. The potency of glycine was low (EC,,, 27 
@WI), and this effect was not due to a direct action on the 
NMDA receptor. The above-mentioned agonists were unable 
to substitute for glycine, even at high concentrations (1 mu). 
On the other hand, @-alanine, taurine, and GABA (1 mu) did 
potentiate NMDA neurotoxicity, and strychnine (I&,, 550 nu) 
could greatly reduce neurotoxicity in the presence of 1 mu 
glycine plus 300 PM NMDA. In addition, replacement of 87% 
of the bath chloride by methanesulfonate, which should limit 
chloride entry through amino acid-receptor channels, pre- 
vented the potentiation of neurotoxicity by glycine. 
These data are consistent with a requirement for glycine 
in NMDA neurotoxicity. They also suggest that the rise in 
cytoplasmic chloride concentration that follows activation of 
the “inhibitory” glycine (and GABA) receptors potentiates 
NMDA-induced neurotoxicity, perhaps by causing neuronal 
swelling or by diverting energy stores for chloride transport 
that would otherwise be used to clear cytosolic calcium. 
These findings emphasize a metabolic coupling between the 
NMDA receptor and inhibitory amino acid receptors. 
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The likely contribution of excessive NMDA-receptor activation 
to the neuropathologies associated with repeated seizures (Siejo 
and Weiloch, 1986), ischemic or hypoxic brain damage (Simon 
et al., 1984; Gill et al., 1987; Ozyurt et al., 1988), and perhaps 
neurodegeneration associated with Huntington’s chorea (Martin 
and Gusella, 1986) and aging (Moroni et al., 1984) is recognized. 
An in vitro culture model has been developed to study the cel- 
lular basis for and pharmacological control of excitotoxicity 
(Rothman, 1983). The majority of neurons in mature cortical 
or hippocampal cultures that have been exposed to NMDA or 
glutamate, or made briefly hypoxic, die over the succeeding 24 
hr (Rothman, 1983; Choi et al., 1987; Fransden and Schousboe, 
1987; Goldberg et al., 1987). A variety of competitive and non- 
competitive NMDA-receptor antagonists prevent much of the 
neurotoxicity caused by hypoxia, or by brief exposure to NMDA 
or glutamate in culture (Goldberg et al., 1987; Rothman et al., 
1987; Choi et al., 1988), which provides strong evidence for the 
involvement of NMDA receptors in the culture model of ex- 
citotoxicity. Of special importance was the observation that post 
hoc administration of NMDA-receptor antagonists effected par- 
tial protection both in vivo (e.g., Gill et al., 1987) and in culture 
(Choi et al., 1988). The possibility that NMDA-receptor block- 
ers might be useful in decreasing brain damage caused by isch- 
emia, hypoxia, or traumatic injury has therefore become of great 
interest. 
The discovery of glycine as a positive modulator of NMDA 
receptors (Johnson and Ascher, 1987) identifies an additional 
potential target for the development of anti-ischemic drugs. The 
pharmacological properties of the glycine site, as assessed in 
voltage-clamp assays of NMDA-induced ionic currents in cul- 
tured neurons or frog oocytes injected with rat brain mRNA, 
are now fairly well understood. For example, the rank order for 
agonist potency at the glycine site expressed in oocytes is 
1 -aminocyclopropanecarboxylic acid (ACC) > glycine > D-ser- 
ine > D-alanine > /I-fluoro-D-alanine > R-(+)cycloserine > 
L-serine > L-alanine (McBain et al., 1989), and the glycine site 
is blocked competitively by several kynurenine and quinoxaline 
derivatives, including 7-chlorokynurenic acid (Kemp et al., 1988; 
Kleckner and Dingledine, 1989). The demonstration that gly- 
tine appears to be required for NMDA-receptor activation, both 
in mRNA-injected frog oocytes (Kleckner and Dingledine, 1988; 
McBain et al., 1989) and in cultured hippocampal neurons 
(Huettner, 1989; Lester et al., 1989; Benveniste et al., 1990) 
suggests that blockers of the glycine recognition site might be 
as efficacious as NMDA blockers of excitotoxicity. The potential 
role of the glycine recognition site in NMDA-receptor-mediated 
neurotoxicity is thus of some importance. The culture system 
provides a good opportunity to explore the role of glycine re- 
ceptors in NMDA-receptor-mediated neurotoxicity. 
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We report here that glycine potentiates and 7-chlorokynurenic 
acid abolishes NMDA-induced toxicity. The glycine site on the 
NMDA receptor is, however, already saturated by ambient gly- 
tine. The potentiation by glycine is shared by other inhibitory 
amino acids and is due to an action on the strychnine-sensitive 
glycine receptor. 
Some of these results were presented to the Society for Neu- 
roscience (McNamara and Dingledine, 1988, 1989). 
On the fourth day after plating, serum was diluted by % by addition 
of chemically defined medium (CDM). This is a growth medium con- 
taining, in Dulbecco’s MEM:Ham’s F12 (3:1), bovine serum albumin 
(6.67 UM). dexamethasone (26.0 nM). B-estradiol(l.0 DM). insulin (0.833 
PM), progesterone (20.0 &), putrescine (1.0 nhr); sodium selenite (30.0 
nM), transferrin (1.25 PM), and tri-iodothreonine (3 10 nM). Prior to 
feeding, this medium was conditioned by incubation for 4-6 hr on a 
monolayer of glial cells, prepared by a method similar to that described 
above but from rats of postnatal age 5-10 d, and maintained in 10% 
FCHS. Subsequent feedings on days 7 and 9 or 10 involved removing 
approximately ‘/2 of the medium from the cells and replacing with glial- 
conditioned CDM. In some experiments, cultures were treated with lO- 
30 PM cytosine arabinoside on day 4-l 1 to retard division of the glial 
cell population. 
Materials and Methods 
Tissue culture. Cerebral cortices were removed from SpragueDawley 
rat embryos on the nineteenth day of gestation. The olfactory bulb and 
meninges were removed, and cortices were minced and incubated in 
0.1% trypsin at 37°C for 20 min. Digestion due to residual enzyme was 
halted by addition of a mixture of 5% fetal calf serum plus 5% heat- 
inactivated horse serum (FCHS) in Eagle’s minimum essential medium 
(MEM). Tissue was then rinsed twice with Hank’s balanced salt solution 
(HBSS) lacking Cal+ and Mg*+ but supplemented with 10 mM HEPES. 
Cells were dissociated by trituration. The resulting suspension was then 
diluted in a plating medium consisting of 10% FCHS in MEM, 2 mM 
L-glutamine, 1 mM sodium pyruvate, sodium bicarbonate (36.5 mM 
total), and glucose (25 mM total). Cells were plated at 0.11 brains per 
35-mm well of 6 well plates and maintained in a humidified incubator 
at 37°C and 8% CO,. 
that could be released into the medium by 1-hr exposure to high con- 
centrations of NMDA and glycine was calculated as the amount released 
during the postexposure incubation divided by the total LDH content 
of the dish. 
Materials. Tissue culture media were obtained from Gibco, and sera 
from Hyclone. NMDA, D-APV, and DL-APV were obtained from Cam- 
bridge Research Biochemicals. Glycine, ACC, n-alanine, and n-serine 
were obtained from Pierce Chemical Company, p-alanine from Aldrich 
Chemical Company, ,&fluoro-D-alanine from Merck Sharp and Dohme 
Research Labs, and @-NADH from Boehringer Mannheim. 7-Chloro- 
kynurenic acid was purchased from Tocris. All other chemicals were 
obtained from Sigma Chemical Company. 
Results 
NMDA-induced neurotoxicitv 
NMDA exposure. On day 11, a freshly made saline solution was used 
to rinse cells and to expose them to excitotoxic amino acids. The usual 
exposure solution differed from HBSS in that it contained no phenol 
red and only 14.3 mM NaHCO,. This solution was made of reagent- 
grade salts in double-distilled water and glassware that had been baked 
at 300°C for 4 hr to reduce glycine. Amino acid stocks and exposure 
solutions were also made up in this saline. 
Rinse and exposure solutions containing varying concentrations of 
amino acids and antagonists were kept at 37°C prior to application to 
the cells. All were applied gently with a syringe or micropipette. Cells 
were rinsed 3 times in saline, each rinse remaining on the cells for 5 
min in the 37°C incubator. Cells were then exposed to NMDA plus 
glycine or analogs for 5 or 10 min (exposure time was consistent within 
an experiment) at 37°C after which time, the exposure solution was 
replaced with CDM in MEM lacking sodium pyruvate but containing 
100 MM DL-APV. DL-APV was included to prevent further activation of 
NMDA receptors by residual NMDA or other agonists released by 
injured cells..To produce maximum injury, cultures were exposed to 
100-300 UM NMDA plus 100-300 YM alvcine for 1 hr (Fransden and 
Schousboe, 1987). After the 5-10-t&; 1-hr exposure period, cells 
were incubated for a further 18-24 hr to allow manifestation of injury. 
Samples of the medium were then collected, and the cells from each 
well were scraped from the plate for measurements of lactate dehydro- 
genase (LDH) released and total tissue LDH, respectively. 
As previously reported for L-glutamate (Choi, 1987; Finkbeiner 
and Stevens, 1988) and NMDA (Frandsen and Schousboe, 1987; 
Pate1 et al., 1990), exposure of rat cortical cultures to 100-300 
PM NMDA for 1 hr produced visually obvious swelling and 
granulation of neurons, followed by degeneration of a propor- 
tion of neurons over the succeeding 18-24 hr. To quantify this 
phenomenon, we measured the fraction of total LDH contained 
within the culture dish that was released into the medium 18- 
24 hr after the initial exposure (Koh and Choi, 1987). Following 
a 1 -hr exposure to NMDA (100-300 KM) plus glycine (100-300 
PM), 30.5 f 1.1% of the total LDH content in the culture dish 
was released into the medium (n = 88), whereas during a 5- or 
lo-min control period without NMDA or glycine, only 5.6 f 
0.3% was released (n = 88). All measurements of NMDA-in- 
duced LDH release were therefore scaled between these 2 values, 
determined separately in each experiment. (In the absence of 
excitotoxins, the baseline release of LDH over a 5-lo-min pe- 
riod was essentially the same as with a 1-hr incubation.) The 
main objective of this study was to examine the roles of glycine 
in NMDA-induced neurotoxicity; accordingly, the period of ex- 
posure to NMDA was 10 min or less so that cell injury (and 
release of endogenous glycine) would be minimal during the 
exposure period. In contrast to most previous studies (Choi et 
al., 1987, 1988; Fransden and Schousboe, 1987; Favaron et al., 
1988; Finkbeiner and Stevens, 1988; Pate1 et al., 1990), DL-APV 
(100 PM) was added to the culture medium after the transient 
exposure to NMDA in order to eliminate additional neurotoxic 
effects of residual NMDA or glutamate that would be released 
from injured neurons in the postincubation period (Hartley and 
Choi, 1989; Shalaby et al., 1989). Thus, the activation ofNMDA 
receptors was confined in all experiments to the 5-lo-min ex- 
posure period. 
LDH assay. Portions of each sample were assayed for LDH activity 
by the method of Koh and Choi (1987). Samples were added to /3-NADH 
(100 PM) in 0.1 M KH,PO, buffer (pH, 7.5). Sodium pyruvate was then 
added to 767 PM, and the absorbance at 340 nm (A& was monitored 
spectrophotometrically. LDH activity in the sample was inferred from 
the rate of change of A,,,. LDH activity was expressed as a percentage 
of the amount released following a I-hr exposure to high NMDA and 
glycine concentrations, which was considered to be maximum release 
(Fransden and Schousboe, 1987). No extra LDH activity was released 
during the 5- or lo-min period of exposure to high concentrations of 
NMDA and glycine. The percentage of total LDH activity available 
Under these conditions, 10 min exposure to NMDA (plus 
300 PM glycine) produced a concentration-dependent release of 
LDH that reached a maximum of about 60% of the total re- 
leasable pool of LDH (Fig. 1A). The EC,, of NMDA was 360 
PM [95% confidence interval (CI), 330400 PM; it = 71, higher 
than that found in previous studies under other conditions (Koh 
et al., 1986; Fransden and Schousboe, 1987; Finkbeiner and 
Stevens, 1988; Pate1 et al., 1990). The low NMDA potency was 
not due to a large proportion of NADPH-diaphorase(+) neu- 
rons, which are selectively resistant to NMDA-receptor-medi- 
ated neurotoxicity (Koh et al., 1986), because our cultures had 
very few diaphorase( +) cells. 
The inclusion of 100 MM D-APV in the lo-min exposure so- 
lution reduced LDH release to background levels as expected 
(see Fig. 2A). The neurotoxic effect of 300 I.LM NMDA plus 300 
PM glycine was also abolished in a dose-dependent manner by 
phencyclidine (IC,,, 4.1 KM) and Mg*+ (IC,,, 7.5 mM; Fig. lB), 
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Figure I. Block of NMDA-induced neurotoxicity. A, Concentration dependence of NMDA-induced neurotoxicity. Exposure of 11 -d-old rat cortical 
neurons for 10 min to 300 PM glycine plus the indicated concentrations of NMDA caused LDH release over the ensuing 18-24 hr. The ordinate 
plots the amount of LDH released as a percent of the (maximum) amount released by a 1-hr exposure to 300 PM NMDA and glycine. The NMDA 
EC,, was 360 FM (95% CI, 330-400 PM; n = 7). The points were fit by a nonlinear least-squares curve-fitting program to a logistic equation: LDH 
release = min + (max - min)/[l + ([agonist]/EC,,)‘], where max is the response at high agonist concentrations, min is the basal LDH release in 
absence of added agonist, and II is the Hill slope coefficient. B, The NMDA-receptor-channel blockers phencyclidine (circles) and magnesium 
(triangles) abolished the toxicity incurred by 1 0-min exposure to 300 PM each of NMDA and glycine. The potency of phencyclidine (IC,,, 4.1 PM; 
95% CI, 0.70-7.2 PM; n = 5) was much higher than that of magnesium (IC,,, 7.5 mM; 95% CI, 5.2-10.0 mM; n = 4). C, Dose-dependent i hibition 
of NMDA-induced neurotoxicity by 7-chlorokynurenate. Cultures were exposed for 10 min to 300 PM NMDA plus the indicated concentrations 
of 7-chlorokynurenate, and LDH release was measured 18-24 hr later. The IC,, of 7-chlorokynurenate was 8.6 PM (95% CI, 1.7-17 PM; n = 4). In 
the absence of 7-chlorokynurenate, NMDA caused the release of 23 f 4.3% of the releasable pool of LDH in these experiments. The error bars 
represent SEM. 
or by reducing the calcium concentration from 1.28 to 0.1 mM 
(D. Mooney, unpublished observations). These results together 
indicate that the neurotoxic effect of NMDA was due to selective 
activation of NMDA receptors. 
Control by glycine of NMDA-induced neurotoxicity 
In the absence of added glycine, 100 or 300 PM NMDA could 
produce some neurotoxicity, releasing 18.3 f 1.2% of the re- 
leasable pool of LDH (n = 58). The competitive antagonist at 
the glycine recognition site of the NMDA receptor, 7-chloro- 
kynurenic acid, could abolish NMDA neurotoxicity. The IC,, 
for 7-chlorokynurenate block of NMDA excitotoxicity in the 
absence of added glycine was 8.6 PM (95% CI, 1.7-17.1 PM; n 
= 4; Fig. lc). Because glycine and 7-chlorokynurenate have 
approximately equal affinities for the glycine recognition site 
(Kemp et al., 1988; Kleckner and Dingledine, 1989), this finding 
is consistent with the presence of about 9 PM glycine in the 
medium above the layer of cultured cells. High-performance 
liquid chromatography (HPLC) analysis of the medium exposed 
to cultured cells revealed about 6 MM glycine in the medium. 
The higher estimate for residual glycine concentration from the 
7-chlorokynurenate IC,, is likely to be due to a higher glycine 
concentration near the cell layer rather than in the bulk solution 
sampled for HPLC measurement. 
In the presence of 30 PM 7-chlorokynurenic acid, the neu- 
rotoxic effect of 300 PM NMDA could be restored by addition 
of glycine (Fig. 2B) or several glycine analogs that are selective 
agonists at the glycine recognition site of the NMDA receptor. 
These include n-serine, ACC, D-alanine, and P-fluoro-D-alanine. 
The relative potencies and relative efficacies of these 5 agonists 
were similar to those described in electrophysiological studies 
of the glycine recognition site expressed in frog oocytes (Table 
1). The cyclic analog ACC was the most potent, yet least effi- 
cacious, agonist in both electrophysiological and neurotoxicity 
assays. 
Modulation by glycine of NMDA-induced neurotoxicity 
In 58 of 7 1 experiments, the addition of glycine to the NMDA 
exposure solution resulted in at least 20% greater cell death than 
for cultures incubated with NMDA alone. The EC,, of glycine 
for potentiating the neurotoxic effect of NMDA was 27 PM (95% 
CI, 15-31 FM; n = 13). Glycine alone (1 mM) was ineffective. 
The maximum effect of glycine was to double the neurotoxic 
effect of NMDA (Fig. 2A). The EC,, of glycine in potentiating 
the neurotoxic effect of NMDA (27 PM) is 50-loo-fold higher 
than that required to permit NMDA-induced cationic currents 
in patch-clamped isolated neurons (Johnson and Ascher, 1987; 
Lester et al., 1989) or voltage-clamped frog oocytes (Kleckner 
and Dingledine, 1988; Kushner et al., 1988; McBain et al., 1989) 
which raises the question of which receptor glycine is acting 
through. 
Several findings indicate that the potentiating effect of glycine 
is not due to its action on the glycine recognition site of the 
NMDA receptor, but rather, to activation of the strychnine- 
sensitive “inhibitory” glycine receptor. First, 30 FM 7-chloro- 
kynurenic acid (100 times its KB for the glycine site on the 
NMDA receptor in electrophysiological or receptor binding as- 
says) shifted the glycine dose-response curve only about 5-fold 
to the right (Fig. 2B). Second, selective agonists at the glycine 
site on NMDA receptors were unable to substitute for glycine 
in the absence of 7-chlorokynurenic acid, presumably because 
this site was already saturated by endogenous glycine. An ex- 
ample ofrobust potentiation by glycine but not D-serine is shown 
in Figure 3. Several other strong agonists at this glycine site, 
including ACC (300 PM, n = 4), D-alanine (300 PM, n = 1 I), 
and /3-fluoro-D-alanine (300 FM, n = 5), were also unable to 
potentiate NMDA-induced neurotoxicity in the absence of 
7-chlorokynurenic acid. These analogs are not likely to be partial 
glycine agonists in this assay because they did not reduce the 
excitotoxic effect of NMDA alone (e.g., Fig. 3), which depends 
on a low ambient glycine concentration (see above). Second, 
both @-alanine and tam-me, which are selective agonists at the 
strychnine-sensitive glycine receptor (e.g., Tokutomi et al., 1989) 
could potentiate NMDA excitotoxicity (Fig. 4). Finally, strych- 
nine could reduce the potentiating effect of 1 mM glycine (Fig. 
5). The block by strychnine may have occurred in 2 phases, the 
higher affinity component (IC,,, 550 nM; 95% CI, 91-940 nM; 
n = 6), apparently due to a selective removal of the glycine- 
potentiated component of neurotoxicity, plus a lower affinity 
action (at 30 PM), possibly due to a direct block of the NMDA 
ion channel (Bertolino and Vicini, 1988). 
These results raise the possibility that the influx of chloride 
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Figure 2. Low potency of glycine in potentiation of NMDA-induced 
neurotoxicity. A, Glycine increased NMDA neurotoxicity in a concen- 
tration-dependent manner. Cultures were exposed to 100 or 300 PM 
NMDA for 10 min in the presence of the indicated concentrations of 
glycine. The EC,, of glycine was 27 PM (95% CI, 15-31 PM; n = 13). 
The NMDA-receptor antagonist D-APV (100 PM; triangle) abolished 
the injury caused by 100 PM glycine and 100 or 300 PM NMDA (n = 
13). B, Dose-response curves for glycine with and without 7-chloro- 
kynnrenate. Cultures were incubated in 300 PM NMDA plus the indi- 
cated concentrations of glycine with (triangles) and without (circles) 30 
PM 7-chlorokynurenate (n = 4 experiments). The EC,, of glycine was 
20 PM in the absence of 7-chlorokynurenate and 30 PM in the presence 
of 7-chlorokynurenate. Under the assumption that glycine is required 
for NMDA neurotoxicity, 7-chlorokynurenate shifted the glycine re- 
sponse about 5-fold along the x-axis. The error bars represent SEM. 
through strychnine-sensitive receptors could be responsible for 
the observed potentiating effect of glycine. This hypothesis was 
supported by 2 additional findings. First, GABA (1 mM) could 
also potentiate the neurotoxic effect of NMDA. In 2 of 3 ex- 
60 
x I I 
i 
-6 -5 -4 -3 
Log added [Agonist], M 
Figure 3. D-Serine alone has no effect on NMDA neurotoxicity. A 
typical experiment (n = 10) wherein increasing concentrations ofglycine 
(circles) produced a significant increase of neurotoxicity induced by 100 
PM NMDA, but D-Wine (triangles) had no effect. The dashed line rep- 
resents the LDH release caused by 100 PM NMDA in the absence of 
glycine or D-serine. 
periments, both GABA and glycine potentiated cell injury caused 
by NMDA; in the third experiment, neither amino acid was 
effective. Second, reduction of the bath chloride concentration 
from 145 to 48 mM by replacement with methanesulfonate, a 
procedure that should limit chloride entry through glycine-ac- 
tivated receptor channels, eliminated the potentiating effects of 
glycine (Fig. 6). Chloride replacement also reduced the neuro- 
toxic effect of NMDA alone, presumably by limiting the initial 
cell swelling that contributes to damage (Rothman, 1985; Choi, 
1987). 
Discussion 
The results provide evidence for 2 distinct roles of glycine in 
the neurotoxic action of NMDA. First, a requirement for glycine 
is suggested because 7-chlorokynurenic acid, a competitive 
blocker of this glycine site (Kemp et al., 1988; Kleckner and 
Dingledine, 1989), could abolish the neurotoxic effect of NMDA. 
The potency of 7-chlorokyuurenic acid (IC,,, 8.6 MM) is predicted 
from the measured levels of glycine in our culture medium, but 
the concentration required for complete protection (30 KM) is 
in the range at which some reduction of AMPA-receptor acti- 
vation may also occur (Kleckuer and Dingledine, 1989). In the 
presence of enough 7-chlorokynurenic acid to displace all en- 
Table 1. Comparison of glycine analogs as potentiators of NMDA-induced neurotoxicity in cell culture 
and ionic currents in oocytes 
EC,, Relative potency Relative efficacy 
95% Cl Tox- oo- Tox- oo- 
Analog PM (PM) n icitya cytes* icity cytesb 
ACC 9 7.8-11 6 2.90 1.93 0.57 k 0.08 0.89 
Glycine 27 22-31 10 1 1 1 1 
D-Serine 47 20-66 7 0.57 0.62 0.93 f  0.08 0.95 
D-Alanine 67 19-115 6 0.40 0.34 0.85 f  0.18 0.85 
fi-Fluoro-D-alanine 97 82-111 7 0.28 0.35 0.65 f  0.11 0.76 
y  Neurotoxicity was evaluated by the amount of LDH released from cultures exposed for 10 min to 300 PM NMDA 
plus 6 concentrations of each glycine analog. 7-Chlorokynurenate (30 I(M) was present in all experiments to eliminate 
the effect of the basal level of glycine present in the culture media. Dose-response curves were fit by a logistic equation, 
from which the EC,, and efficacy (relative to that of glycine determined in the same experiments) were calculated. 
* Data were taken from McBain et al. (1989), in which the ability of glycine analog to pennit NMDA-evoked ionic 
current in voltage-clamped Xenopus oocytes was determined. 








Figure 4. Potentiation of NMDA neurotoxicity by agonists of inhib- 
itory glycine receptor. Cortical neurons were exposed to 300 PM NMDA 
alone and with 1 mM glycine, @-alanine, or taurine. In 7 experiments, 
these agonists increased the injury caused by NMDA exposure with the 
relative effectiveness: fl-alanine > taurine > glycine. As with glycine, 
neither fi-alanine nor taurine caused any injury when exposed to neurons 
in the absence of NMDA. In these 7 experiments, the 22% mean po- 
tentiation by glycine did not reach statistical significance. The effects of 
fi-alanine (P < 0.01) and taurine (P < 0.02) were, however, significantly 
different from that of NMDA alone. The error bars represent SEM. 
dogenous glycine from its recognition site on the NMDA re- 
ceptor (30 PM), 5 selective agonists at this site were able to restore 
the neurotoxic effect of NMDA, and their relative potency and 
efficacy were as previously reported in electrophysiological 
(McBain et al., 1989) and receptor binding (Snell et al., 1988; 
Marvizon et al., 1989) studies of the glycine site on NMDA 
receptors. Thus, in agreement with Pate1 et al. (1990), our data 
would support a permissive role for glycine in the neurotoxic 
action of NMDA on cortical neurons. 
A component of ischemic forebrain damage in the gerbil and 
rat can be prevented by competitive (Simon et al., 1984) and 
uncompetitive (e.g., Gill et al., 1987) blockers of the NMDA 
receptor. Whether glycine-site blockade is also protective in 
intact animals is not known. The present results, and those of 
Pate1 et al. (1990) and Shalaby et al. (1989), indicate that glycine- 
site blockade can provide complete protection of cortical neu- 
Log [Strychnine], M 
Figure 5. Strychnine dose-dependently reduced injury caused by 1 O- 
min exposure to 300 PM NMDA and 1 mM glycine. This effect was 
apparently biphasic, with an IC,, for the higher affinity component of 
550 nM (95W CI, 9 l-940 nM; n = 6). This phase is presumably an action 
on the classical glycine receptor. Additional block by 30 NM strychnine 
may reflect voltage-dependent channel block reported by Bertolino and 
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Figure 6. Effect of decreased chloride concentration on neurotoxicity. 
Glycine (1 mM) increased the LDH released by a IO-min exposure to 
300 PM NMDA from 22% to 28% of maximum release (open columns; 
P < 0.05, n = 6). Replacement of 97 mM of chloride with methane- 
sulfonate, however, eliminated the ability of 1 mM glycine to potentiate 
NMDA-induced neurotoxicity (hatched columns; n = 6). LDH release 
is plotted as a percent of the NMDA-releasable pool in 145 mM chloride. 
The error bars represent SEM. 
rons in culture from the excitotoxic effects of NMDA-receptor 
activation. The in vivo efficacy as anti-ischemic agents of drugs 
targeted to the glycine recognition site will, however, depend on 
how high the ambient glycine concentration is in the ischemic 
area. 
The second role of glycine appears indirect, not mediated by 
its recognition site on the NMDA receptor. Glycine itself po- 
tentiated the neurotoxic effect of NMDA, but in this case, via 
the strychnine-sensitive “inhibitory” glycine receptor. The re- 
quired concentration of glycine was 50-loo-fold higher than 
that required to activate the NMDA receptor, though similar 
to that acting on the classical glycine receptor (Tokutomi et al., 
1989). The potentiating effects of much lower glycine concen- 
trations reported by Finkbeiner and Stevens (1988) and Pate1 
et al. (1990) are presumably due to an ambient glycine level in 
their cultures that is subsaturating for the NMDA receptor. Two 
selective agonists of the strychnine-sensitive receptor, p-alanine 
and tam-me, also potentiated the neurotoxic action of NMDA, 
and the effect of glycine was blocked by strychnine. Although 
strychnine binding sites are very sparse in the adult rat cortex 
(Bristow et al., 1986), other evidence suggests that the neurons 
in our cultures should express some classical glycine receptors. 
Akagi and Miledi (1988) showed that mRNA encoding inhib- 
itory glycine receptors could be isolated from the adult rat cor- 
tex, and Dichter (1980) reported that strychnine-sensitive con- 
ductance increases could be evoked by glycine applied to rat 
cortical neurons in culture. 
Because the neurotoxic effect of NMDA could also be poten- 
tiated by GABA, and the potentiation by glycine could be elim- 
inated by reducing the chloride gradient across the neuron mem- 
brane, we suggest that loading neurons with Cl- is the key event 
in this modulatory action of the inhibitory amino acids. It is 
thought that the rise in [Cal, caused by massive NMDA-receptor 
activation mediates much of the ensuing neuron injury (Choi, 
1987; Manev et al., 1989; but see Rothman, 1985; Olney et al., 
1986). Moreover, NMDA-mediated neurotoxicity is greater at 
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room temperature than at 37°C (Favaron et al., 1988), possibly 
due to a slower or less effective clearance of [Cal, at the lower 
temperature. We suggest that the extra metabolic burden of 
transporting Cl- to reestablish a normal Cl- gradient may divert 
energy supplies that would otherwise be used to pump Ca*+ 
out of the cytoplasm. The reduction of energy stores by hypo- 
glycemia also enhances the neurotoxic effect of NMDA-receptor 
activation (Novelli et al., 1988). 
Thus, the activation of inhibitory amino acid receptors would 
have 2 opposing actions on neurotoxicity mediated by NMDA 
receptors: a protective effect of hyperpolarization that enhances 
voltage-dependent Mg*+ block (Mayer et al., 1984; Nowak et 
al., 1984) and if NMDA receptors break through the Mg*+ block, 
a metabolic depletion of energy reserves that exacerbates neu- 
rotoxicity. Alternative explanations for potentiation by glycine 
would involve intracellular pH imbalance due to disruption of 
Cl--bicarbonate exchange, or a direct effect of neuronal swelling 
accompanying Cl- loading. 
Although the block of NMDA-evoked neurotoxicity by 
D-APV, 7-chlorokynurenic acid, phencyclidine, and low [Cal,, 
argues that this action is mediated by NMDA receptors, the low 
potency of both NMDA (EC,,, 364 PM) and Mg*+ (IC,,, 7.5 mM) 
in this assay deserves comment. The low potency of NMDA 
may be due to the inclusion of D-APV in the postincubation 
culture media and the use of an incubation temperature of 37°C 
rather than room temperature, because the higher temperature 
is reported to cause a 50-fold increase in the glutamate LD,, in 
cerebellar or cortical cultures (Favaron et al., 1988). Another 
contributing factor may have been a high proportion of GA- 
BAergic neurons in our cultures (cf. Hoch and Dingledine, 1986), 
which are known to be much less sensitive to the neurotoxic 
effect of NMDA (Tecoma and Choi, 1989). 
The potency of Mg *+ is that predicted (Ascher and Nowak, 
1988; Kleckner and Dingledine, 1990) for neurons depolarized 
to near 0 mV by NMDA, because the potency of this blocker 
is voltage dependent. The reason for the higher potency of phen- 
cyclidine is less clear. The great difference in half-time for dis- 
sociation from open NMDA channels of Mg2+ (2-3 msec; Mayer 
and Westbrook, 1985) and phencyclidine or its analogs (several 
min; Kloog et al., 1988; see also MacDonald et al., 1987; Kush- 
ner et al., 1988) probably accounts for the difference in potency 
of the 2 blockers observed over a 5-lo-min incubation period 
(Fig. li?). 
In sum, evidence for 2 distinct effects of glycine on NMDA- 
induced neurotoxicity was produced: a direct permissive action 
on the NMDA receptor itself and a modulatory, presumably 
metabolic, effect (shared by other inhibitory amino acids) me- 
diated by Cl- loading of the neurons. The indirect potentiation 
by inhibitory amino acids of NMDA-receptor-mediated neu- 
rotoxicity is unexpected and underscores the complexity of the 
control of NMDA-receptor activation by cortical neurons. 
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